1-Boc-4-(Aminomethyl)piperidine hydrochloride

Catalog No. :
ACHXEM378
CAS No. :
359629-16-6
Molecular Formula :
C11H23ClN2O2
Molecular Weight :
250.77

IUPAC Name:tert-butyl 4-(aminomethyl)piperidine-1-carboxylate hydrochloride

1-Boc-4-(Aminomethyl)piperidine hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$113.00Login to see priceIn stockIn stock
100g97%$379.00Login to see priceInquiryIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-Boc-4-(Aminomethyl)piperidine hydrochloride
IUPAC Nametert-butyl 4-(aminomethyl)piperidine-1-carboxylate hydrochloride
MDL No.MFCD03093510
Molecular FormulaC11H23ClN2O2
Molecular Weight250.77
SMILESNCC1CCN(C(OC(C)(C)C)=O)CC1.[H]Cl
InChI KeyDSXFEYYTYBXYMB-UHFFFAOYSA-N
SynonymBOC-PIP(4-AM) HCL;1-TERT-BUTYLOXYCARBONYL-4-(AMINOMETHYL)-PIPERIDINE HYDROCHLORIDE;1-BOC-4-AMINOMETHYL-PIPERIDINE HYDROCHLORIDE;4-(Aminomethyl)-1-tert-butoxycarbonylpiperidineHCl;tert-butyl 4-(aminomethyl)piperidine-1-carboxylate hydrochloride;1-Boc-4-aMinoMethyl-piperidine HCl;4-(AMINOMETHYL)-1-N-BOC-PIPERIDINE-HCl;4-(Aminomethyl)-1-tert-butoxycarbonylpiperidine hydrochloride
CAS No.359629-16-6
PubChem CID2756034

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P301+P312+P330

Synthetic Route by SureRoute

1. ACHXEM378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHXEM378 route product structure diagram
    ACHXEM378359629-16-6 In Stock
Inquiry

2. ACHXEM378 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHXEM378 route product structure diagram
    ACHXEM378359629-16-6 In Stock
Inquiry

Comments (0)